Tons of new drugs are never even marketed in Canada due to this, or marketed much later.

Almost all expensive drugs end up being on a special permission list, where you must to beg the government for access.

Not any different than dealing with an insurance company, really. At least you can sue an insurer.

You can sue the province too.

However of course consider delays in getting a drug to market aren’t always provincial; Health Canada has their own timelines and schedules for approvals, sometimes it’s faster than in America and sometimes it’s slower.

The difference is frequently you’re forced to sue insurers as they have a profit motive to screw you. The province only cares about getting you healthy within their means.

It has benefits but also obviously drawbacks.

Ambien is not available in Canada for example.

One of the things about hard negotiations is that sometimes the other side will call the bluff and walk away.

And of course in rationed systems you don't get things that 'the masters' decide you don't need, like Ambien.

In the case of Ambien, I don't care, I question the real medical value of it, but you can see how that could get out of hand with other things.

It would better to solve the 're-import' problem with better regulation - and of course, initiatives such as the the MC Company here.

I think the Cleveland Clinic and some others like it are technically non-profits, there are models that work.

The thing about MC company is they have no obligation to keep their pricing or business model moving forward. They can sell to an insurer or pharma company or just raise their margins. This is good but shouldn’t be integral.